"Discover the latest patent lawsuits in the orthopedic and spine industry, including revocations, wins, and agreements between major devicemakers. Stay informed
Nevro Corp. (NYSE:NVRO) Q4 2023 Earnings Call Transcript February 21, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.5. Nevro Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Nevro’s Fourth […]
"European Patent Office revokes pain management patent belonging to Nevro after challenge from Medtronic and Boston Scientific. Learn more in Life Sciences Inte